1
项与 Hepatitis B vaccine(Henogen) 相关的临床试验A Study to Evaluate the Persistence of Anti-HBs Antibodies at Months 12, 24 and 36 in Pre-dialysis or Dialysis Patients Who Have Received a Primary Vaccination Course of Either Henogen's HBV Vaccine, HB-AS02V or GSK Biological's Fendrix™
The current extension study will assess the persistence of anti-HBs antibodies at Months 12, 24 and 36 after primary vaccination with Henogen's HBV vaccine or Fendrix™. This protocol posting deals with the objectives & outcome measures of the extension phase at Months 12, 24 and 36. The objectives & outcome measures of the primary phase are presented in a separate protocol posting (NCT00291941).
100 项与 Hepatitis B vaccine(Henogen) 相关的临床结果
100 项与 Hepatitis B vaccine(Henogen) 相关的转化医学
100 项与 Hepatitis B vaccine(Henogen) 相关的专利(医药)
100 项与 Hepatitis B vaccine(Henogen) 相关的药物交易